Zum Hauptinhalt springen

Cooperation between prokaryotic (Lde) and eukaryotic (MRP) efflux transporters in J774 macrophages infected with Listeria monocytogenes: studies with ciprofloxacin and moxifloxacin.

Lismond, A ; Tulkens, PM ; et al.
In: Antimicrobial agents and chemotherapy, Jg. 52 (2008-09-01), Heft 9, S. 3040-6
Online academicJournal

Titel:
Cooperation between prokaryotic (Lde) and eukaryotic (MRP) efflux transporters in J774 macrophages infected with Listeria monocytogenes: studies with ciprofloxacin and moxifloxacin.
Autor/in / Beteiligte Person: Lismond, A ; Tulkens, PM ; Mingeot-Leclercq, MP ; Courvalin, P ; Van Bambeke, F
Link:
Zeitschrift: Antimicrobial agents and chemotherapy, Jg. 52 (2008-09-01), Heft 9, S. 3040-6
Veröffentlichung: Washington, American Society for Microbiology, 2008
Medientyp: academicJournal
ISSN: 1098-6596 (electronic)
DOI: 10.1128/AAC.00105-08
Schlagwort:
  • Animals
  • Anti-Bacterial Agents pharmacology
  • Cell Line
  • Drug Resistance
  • Drug Resistance, Bacterial
  • Fluoroquinolones
  • Humans
  • Listeria monocytogenes pathogenicity
  • Mice
  • Microbial Sensitivity Tests
  • Moxifloxacin
  • Anti-Infective Agents pharmacology
  • Aza Compounds pharmacology
  • Ciprofloxacin pharmacology
  • Listeria monocytogenes drug effects
  • Macrophages drug effects
  • Macrophages microbiology
  • Membrane Transport Proteins metabolism
  • Multidrug Resistance-Associated Proteins metabolism
  • Quinolines pharmacology
Sonstiges:
  • Nachgewiesen in: MEDLINE
  • Sprachen: English
  • Publication Type: Journal Article; Research Support, Non-U.S. Gov't
  • Language: English
  • [Antimicrob Agents Chemother] 2008 Sep; Vol. 52 (9), pp. 3040-6. <i>Date of Electronic Publication: </i>2008 Jun 23.
  • MeSH Terms: Macrophages* / drug effects ; Macrophages* / microbiology ; Anti-Infective Agents / *pharmacology ; Aza Compounds / *pharmacology ; Ciprofloxacin / *pharmacology ; Listeria monocytogenes / *drug effects ; Membrane Transport Proteins / *metabolism ; Multidrug Resistance-Associated Proteins / *metabolism ; Quinolines / *pharmacology ; Animals ; Anti-Bacterial Agents / pharmacology ; Cell Line ; Drug Resistance ; Drug Resistance, Bacterial ; Fluoroquinolones ; Humans ; Listeria monocytogenes / pathogenicity ; Mice ; Microbial Sensitivity Tests ; Moxifloxacin
  • References: Eur J Pharm Sci. 2000 Oct;11(4):265-83. (PMID: 11033070) ; Antimicrob Agents Chemother. 2003 Feb;47(2):704-8. (PMID: 12543681) ; Mol Pharmacol. 2002 May;61(5):974-81. (PMID: 11961114) ; Antimicrob Agents Chemother. 1993 Jan;37(1):128-9. (PMID: 8431010) ; Cancer Chemother Pharmacol. 2007 Jan;59(1):79-87. (PMID: 16642371) ; Antimicrob Agents Chemother. 2008 May;52(5):1697-702. (PMID: 18299415) ; J Antimicrob Chemother. 2007 Jun;59(6):1237-46. (PMID: 17218448) ; Arch Biochem Biophys. 1995 Jan 10;316(1):77-82. (PMID: 7840681) ; J Biol Chem. 1951 Nov;193(1):265-75. (PMID: 14907713) ; Clin Pharmacokinet. 1981 Mar-Apr;6(2):135-51. (PMID: 7011657) ; FEBS Lett. 2006 Feb 13;580(4):1103-11. (PMID: 16387301) ; Antimicrob Agents Chemother. 2004 Jul;48(7):2673-82. (PMID: 15215125) ; J Antimicrob Chemother. 2003 May;51(5):1067-77. (PMID: 12697641) ; Biochem Pharmacol. 1994 Sep 15;48(6):1129-36. (PMID: 7945406) ; J Antimicrob Chemother. 2003 May;51(5):1167-73. (PMID: 12697643) ; Antimicrob Agents Chemother. 2002 Mar;46(3):808-12. (PMID: 11850265) ; J Infect Dis. 1992 Feb;165(2):322-8. (PMID: 1730899) ; Antimicrob Agents Chemother. 2005 Jun;49(6):2429-37. (PMID: 15917543) ; J Pharm Biomed Anal. 2006 Apr 11;41(1):251-5. (PMID: 16311002) ; Antimicrob Agents Chemother. 2006 May;50(5):1689-95. (PMID: 16641436) ; Curr Med Chem Anticancer Agents. 2004 Jan;4(1):43-52. (PMID: 14754411) ; Curr Drug Targets. 2006 Jul;7(7):893-909. (PMID: 16842220) ; Antimicrob Agents Chemother. 2006 Aug;50(8):2824-8. (PMID: 16870778) ; Carcinogenesis. 2005 Oct;26(10):1754-63. (PMID: 15917307) ; Antimicrob Agents Chemother. 2002 Jul;46(7):2095-103. (PMID: 12069960) ; Biochem Biophys Res Commun. 2001 Nov 30;289(2):580-5. (PMID: 11716514) ; J Antimicrob Chemother. 2005 Apr;55(4):511-7. (PMID: 15731197) ; Antimicrob Agents Chemother. 1999 May;43(5):1242-51. (PMID: 10223943) ; J Bioenerg Biomembr. 2001 Dec;33(6):493-501. (PMID: 11804191) ; Cancer Chemother Pharmacol. 1997;40(2):150-8. (PMID: 9182837) ; Biochem Biophys Res Commun. 2008 Jan 11;365(2):310-5. (PMID: 17996193) ; Exp Cell Res. 2002 Nov 15;281(1):86-100. (PMID: 12441132) ; Biochem Pharmacol. 2000 Aug 15;60(4):457-70. (PMID: 10874120) ; Eur J Pharmacol. 2004 Jan 26;484(2-3):333-9. (PMID: 14744620) ; J Pharmacol Exp Ther. 2002 Oct;303(1):323-32. (PMID: 12235267) ; J Antimicrob Chemother. 2003 May;51(5):1055-65. (PMID: 12697642) ; Antimicrob Agents Chemother. 2003 Dec;47(12):3733-8. (PMID: 14638474) ; Recent Pat Antiinfect Drug Discov. 2006 Jun;1(2):157-75. (PMID: 18221142) ; Antimicrob Agents Chemother. 2007 Aug;51(8):2748-57. (PMID: 17548493)
  • Substance Nomenclature: 0 (Anti-Bacterial Agents) ; 0 (Anti-Infective Agents) ; 0 (Aza Compounds) ; 0 (Fluoroquinolones) ; 0 (Membrane Transport Proteins) ; 0 (Multidrug Resistance-Associated Proteins) ; 0 (Quinolines) ; 5E8K9I0O4U (Ciprofloxacin) ; U188XYD42P (Moxifloxacin)
  • Entry Date(s): Date Created: 20080625 Date Completed: 20081023 Latest Revision: 20211020
  • Update Code: 20240513
  • PubMed Central ID: PMC2533462

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -